Washington People: Daniel Coyne, MD
Daniel Coyne, MD, specializes in the treatment of patients on dialysis. He’s a strong believer in seeing that patients’ interests are put first. That philosophy spurred him to fight against the overuse of the anti-anemia drug Epogen in dialysis patients. The drug increases the risk of heart attacks and strokes and at one time was one of the top-selling prescription medicines in the United States.
‘An honest compassion’
Amy Waterman, Ph.D., assistant professor of medicine, is tackling a vexing health problem: There are not enough kidneys for transplants, but patients with kidney failure who choose transplants over dialysis have longer, healthier lives.
Researchers study reimbursing living organ donors for out-of-pocket expenses
More than 80,000 people in the U.S. are on waiting lists for organ transplants. Some will have to wait for the death of a matching donor, but more and more people are receiving organs from living donors. In an effort to close the gap between organ supply and demand, researchers at Washington University School of Medicine, the University of Michigan and the American Society of Transplant Surgeons are studying ways to reimburse living donors for some of their out-of-pocket expenses when they choose to donate an organ.
Researchers study reimbursing living organ donors for out-of-pocket expenses
More than 80,000 people in the United States are on waiting lists for organ transplants. Some will have to wait for the death of a matching donor, but more and more people are receiving organs from living donors. In an effort to close the gap between organ supply and demand, researchers at Washington University School of Medicine, the University of Michigan and the American Society of Transplant Surgeons are studying ways to reimburse living donors for some of their out-of-pocket expenses when they choose to donate an organ.
Researchers calculate cost-savings of living kidney donors
Photo by Bob Boston / WUSTL PhotoWhat might it cost to get more patients off kidney dialysis?Of the 55,000 Americans waiting for kidney transplants, last year only 13,000 had the operation. Some 3,000 others died on the waiting list. Part of the problem involves obtaining donated organs. Currently only half of potential organ donors actually donate, but even if every eligible donor donated, many on the waiting list still wouldn’t be helped. Living donors are another potential source of organs, and the transplants from living donors also have the greatest chance of success. Encouraging more people to donate a kidney while they are alive could put a big dent in the number of people on the waiting list, but how can society encourage more of those people to donate? Researchers at Washington University School of Medicine in St. Louis and the University of Minnesota set up a mathematical model to determine whether it might be cost effective to pay people for their kidneys. Potential ethical issues aside, the researchers determined that society could break even by paying as much as $90,000 to those willing to part with a kidney for money.